Inspire Medical (INSP) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.14
- EPS estimate
- −$0.24
- EPS surprise
- +159.35%
- Revenue surprise
- +3.01%
- Revenue
- $200.6M
- Revenue estimate
- $194.7M
- Reported
- Aug 3, 2026
Inspire Medical reported Q2 2026 results on August 3, 2026. Earnings per share were $0.14, a profit against an expected loss of $0.24, a beat of 159.35%. Revenue was $200.6 million, above the $194.7 million estimate. Compared with Q2 2025, though, EPS fell about 69% from $0.45 and revenue fell 7.6% from $217.1 million.
Over the longer record the company moved from losses to profits. Annual EPS went from a $1.64 loss in 2022 and a $0.74 loss in 2023 to profits of $1.73 in 2024 and $2.58 in 2025. Revenue grew each year, from $407.9 million in 2022 to $912.0 million in 2025, up 13.6% in the latest year. Q4 is the largest quarter of each year in the table, and Q4 2025 set the highs here at $1.65 per share and $269.1 million in revenue. The first half of 2026 brought $405.2 million of revenue, 3.2% less than a year earlier, and EPS of $0.24 against $0.55. Inspire beat the EPS estimate in all 20 quarters shown.
Third-quarter results have come out in early November in each of the past five years. That points to early November 2026 for the next report.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | −$0.24 | $0.14 | +159.35% | $200.6M | SEC |
| Q1 2026 | May 4, 2026 | −$0.28 | $0.10 | +136.32% | $204.6M | SEC |
| Q4 2025 | Feb 11, 2026 | $0.68 | $1.65 | +143.87% | $269.1M | SEC |
| Q3 2025 | Nov 3, 2025 | −$0.19 | $0.38 | +300.63% | $224.5M | SEC |
| Q2 2025 | Aug 4, 2025 | $0.20 | $0.45 | +122.88% | $217.1M | SEC |
| Q1 2025 | May 5, 2025 | −$0.25 | $0.10 | +140.32% | $201.3M | SEC |
| Q4 2024 | Feb 10, 2025 | $0.73 | $1.15 | +57.21% | $239.7M | SEC |
| Q3 2024 | Nov 4, 2024 | $0.06 | $0.60 | +875.61% | $203.2M | SEC |
| Q2 2024 | Aug 6, 2024 | −$0.14 | $0.32 | +328.90% | $195.9M | SEC |
| Q1 2024 | May 7, 2024 | −$0.65 | −$0.34 | +47.80% | $164.0M | SEC |
| Q4 2023 | Feb 6, 2024 | −$0.05 | $0.49 | +1015.89% | $192.5M | SEC |
| Q3 2023 | Nov 7, 2023 | −$0.58 | −$0.29 | +50.00% | $153.3M | SEC |
| Q2 2023 | Aug 1, 2023 | −$0.57 | −$0.41 | +28.01% | $151.1M | SEC |
| Q1 2023 | May 2, 2023 | −$0.66 | −$0.53 | +19.73% | $127.9M | SEC |
| Q4 2022 | Feb 7, 2023 | −$0.61 | $0.10 | +116.48% | $137.9M | SEC |
| Q3 2022 | Nov 1, 2022 | −$0.76 | −$0.60 | +20.59% | $109.2M | SEC |
| Q2 2022 | Aug 2, 2022 | −$0.61 | −$0.53 | +12.94% | $91.4M | SEC |
| Q1 2022 | May 3, 2022 | −$0.80 | −$0.61 | +23.37% | $69.4M | SEC |
| Q4 2021 | Feb 8, 2022 | −$0.44 | −$0.09 | +79.42% | $78.4M | SEC |
| Q3 2021 | Nov 2, 2021 | −$0.61 | −$0.38 | +38.16% | $61.7M | SEC |
Quarterly revenue
Frequently asked questions
When did Inspire Medical (INSP) last report earnings?
Inspire Medical last reported on Aug 3, 2026, covering fiscal Q2 2026.
Did INSP beat earnings estimates?
Yes. Inspire Medical reported EPS of $0.14 for Q2 2026 against a −$0.24 estimate — a 159.35% beat.
How much revenue did INSP report last quarter?
Inspire Medical reported $200.6M in revenue for Q2 2026, against a consensus estimate of $194.7M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.